To help get this prescription medication approved, the patient must show some attempt at weight loss before initiation
Further research, including long-term evaluation of sarcopenia in GLP-1RAs trials, development of standardized monitoring protocols and investigation of combined nutritional, exercise and pharmacologic strategies, is needed in order to prevent muscle loss while maximizing metabolic benefits under GLP-1RAs treatment
Additionally, the convenience of Tremfyas dosing regimen and its favorable safety profile enhanced patient adherence and satisfaction
[1] [2] However, some patients report experiencing skin changes, including acne or worsening of pre-existing acne, during treatment
Learn More IMMUSE Lactococcus lactis strain Plasma IMMUSE, a novel postbiotic, is the first lactic acid bacteria to activate comprehensive immune support backed by 29 studies, including 14 human trials